Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab

Acta Oncol. 2008;47(8):1600-1. doi: 10.1080/02841860801978905.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Aortic Aneurysm / chemically induced*
  • Aortic Aneurysm / drug therapy
  • Aortic Aneurysm / pathology
  • Aortic Dissection / chemically induced*
  • Aortic Dissection / drug therapy
  • Aortic Dissection / pathology
  • Bevacizumab
  • Humans
  • Hypertension / complications*
  • Hypertension / drug therapy
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / surgery
  • Tomography, X-Ray Computed
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab